Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
Reset all filters
01 1Farmhispania, S.A. Montmeló ES
02 1ALEMBIC PHARMACEUTICALS LIMITED Vadodara IN
03 1CIPLA LIMITED Mumbai IN
04 1HETERO LABS LIMITED Hyderabad IN
05 1MAC CHEM PRODUCTS (INDIA) PVT. LTD. Mumbai IN
06 1MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN
07 1NATCO PHARMA LIMITED Hyderabad IN
08 1SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou City CN
09 1SICHUAN XIELI PHARMACEUTICAL CO., LTD. Pengzhou CN
10 1SYNTHON BV Nijmegen NL
11 1Wisdom Pharmaceutical Co., Ltd. Haimen CN
12 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN
13 1Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou City CN
Reset all filters
01 10Gefitinib
02 1Gefitinib, Form-I
03 2Gefitinib, Micronised
Reset all filters
01 5China
02 6India
03 1Netherlands
04 1Spain
Reset all filters
01 1Expired
02 11Valid
03 1Withdrawn by Holder
Certificate Number : R1-CEP 2016-305 - Rev 00
Status : Valid
Issue Date : 2022-10-06
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2018-087 - Rev 01
Status : Valid
Issue Date : 2024-04-05
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2017-002 - Rev 01
Status : Valid
Issue Date : 2025-05-21
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2018-031 - Rev 01
Status : Valid
Issue Date : 2024-10-14
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2017-244 - Rev 02
Status : Valid
Issue Date : 2024-02-07
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2017-028 - Rev 01
Status : Valid
Issue Date : 2024-04-29
Type : Chemical
Substance Number : 2866
Certificate Number : R1-CEP 2016-154 - Rev 00
Status : Valid
Issue Date : 2022-06-07
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2022-291 - Rev 00
Status : Valid
Issue Date : 2024-04-02
Type : Chemical
Substance Number : 2866
Certificate Number : R1-CEP 2016-241 - Rev 00
Status : Valid
Issue Date : 2022-11-08
Type : Chemical
Substance Number : 2866
Certificate Number : R0-CEP 2018-236 - Rev 01
Status : Valid
Issue Date : 2022-02-02
Type : Chemical
Substance Number : 2866
47
PharmaCompass offers a list of Gefitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gefitinib manufacturer or Gefitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gefitinib manufacturer or Gefitinib supplier.
PharmaCompass also assists you with knowing the Gefitinib API Price utilized in the formulation of products. Gefitinib API Price is not always fixed or binding as the Gefitinib Price is obtained through a variety of data sources. The Gefitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gefitinib - Iressa manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gefitinib - Iressa, including repackagers and relabelers. The FDA regulates Gefitinib - Iressa manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gefitinib - Iressa API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gefitinib - Iressa manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gefitinib - Iressa supplier is an individual or a company that provides Gefitinib - Iressa active pharmaceutical ingredient (API) or Gefitinib - Iressa finished formulations upon request. The Gefitinib - Iressa suppliers may include Gefitinib - Iressa API manufacturers, exporters, distributors and traders.
click here to find a list of Gefitinib - Iressa suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gefitinib - Iressa CEP of the European Pharmacopoeia monograph is often referred to as a Gefitinib - Iressa Certificate of Suitability (COS). The purpose of a Gefitinib - Iressa CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gefitinib - Iressa EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gefitinib - Iressa to their clients by showing that a Gefitinib - Iressa CEP has been issued for it. The manufacturer submits a Gefitinib - Iressa CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gefitinib - Iressa CEP holder for the record. Additionally, the data presented in the Gefitinib - Iressa CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gefitinib - Iressa DMF.
A Gefitinib - Iressa CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gefitinib - Iressa CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gefitinib - Iressa suppliers with CEP (COS) on PharmaCompass.
We have 13 companies offering Gefitinib - Iressa
Get in contact with the supplier of your choice: